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Men’s increased risk of death in ART programmes in sub-Saharan Africa is widely reported but poorly understood. Some studies 
have attributed this risk to men’s poorer health-seeking behaviour, which may prevent them from accessing ART, being adherent 
to treatment, or remaining in care. In a multicentre analysis of 46 201 adults starting ART in urban and rural settings in South 
Africa, these factors only partly explained men’s increased mortality while receiving ART. Importantly, the gender difference in 
mortality among patients receiving ART (31% higher for men than women) was substantially smaller than that among HIV-
negative South Africans, where men had twice the risk of death compared with women. Yet, this extreme gender inequality in 
mortality, both within and outside of ART programmes, has not given rise to widespread action. Here it is argued that, despite 
their dominance in society, men may be subject to a wide range of unfair discriminatory practices, which negatively affect their 
health outcomes. The health needs of men and boys require urgent attention.
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Sub-Saharan Africa is the centre of the HIV epidemic, with 
an estimated 68% of all people HIV-infected.[1] Over the past 
10 years, largely through international aid programmes, there 
has been a dramatic increase in the number of HIV-infected 
individuals who have started antiretroviral therapy (ART) 
in the region. Despite early concerns that women may be 
disadvantaged in ART programmes, disproportionately more 
women than men have accessed ART in Southern Africa.[2] In 
South Africa, for example, 60% of eligible women were receiving 
ART by mid-2011 compared with 41% of eligible men.[3] 
Men have a higher mortality than women when receiving 
ART.[4-8] Although the reasons for this are poorly understood, 
a number of possible explanations have been suggested; some 
implicitly blame men for their own poorer outcomes. For 
example, numerous studies have suggested that men’s poorer 
‘health-seeking behaviour’ may prevent them from accessing 
ART services, being adherent to treatment or remaining in care. 
But, is this based on evidence or is it an assumption that has 
gained currency through widespread usage?  
To date, there has been no systematic attempt to understand 
the phenomenon of gender differences on ART. In the past 
year, we explored the issue in an analysis including 46  201 
adults initiating ART in 8 large urban and rural South African 
cohorts between 2002 and 2009.[5] As 60% of our patients had 
civil identification (ID) numbers, it was possible to confirm 
their vital status through linkage to the National Population 
Register, estimated to capture over 90% of deaths nationally. [9] 
We were also able to track patients with IDs after they were 
lost to follow-up (LTF) and confirm whether they were alive 
or dead.
Men’s increased mortality on 
ART unrelated to HIV/AIDS
At the start of treatment, on average men had lower CD4+ cell 
counts and more advanced HIV disease than women. After we 
adjusted for such gender differences at ART initiation, men still 
had a 31% higher risk of mortality than women over 36 months 
(adjusted hazard ratio (AHR) 1.31, 95% confidence interval (CI) 
1.22 - 1.41). Men were more likely to be LTF than women (AHR 
1.20, 95% CI 1.12 - 1.28), but not to die after being LTF (AHR 
1.04, 95% CI 0.86 - 1.25). Virological responses to ART were 
similar between men and women and, even among virologically 
suppressed patients, men were still more likely to die. Women 
had slightly stronger immunological responses than men, 
but in analyses restricted to patients who had reached CD4+ 
cell counts ≥200 cells/µl, the gender difference in mortality 
persisted (AHR 1.37, 95% CI 1.03 - 1.83). Importantly, however, 
this difference was smaller than the gender difference in death 
rates (standardised by age) in a hypothetical cohort of HIV-
negative South Africans, where men were twice as likely to 
die than women. It appears then that the observed differences 
in mortality while receiving ART may best be explained by 
background gender differences in mortality in the South 
African population that are unrelated to HIV/AIDS.  
Some more equal than 
others?
The gender differences in mortality outside of ART programmes 
suggest a situation of extreme gender inequality. The World 
Health Organization (WHO) defines gender inequality as 
‘difference(s) between men and women which systematically 
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empower one group to the detriment of the other’ and which impact 
negatively on access to healthcare and health status.[10] Section 9 of 
the South African Bill of Rights states unequivocally that ‘everyone 
is equal before the law’.[11] Equality includes protection against unfair 
discrimination (both direct and indirect) on the grounds of gender, and 
discrimination on any of the grounds mentioned is regarded as unfair 
unless proven to be fair. But, for many of us, discrimination seems a 
vague and unmeasurable concept. We have an intuitive sense of what it 
means, but how do we study it in order to address it? Krieger provides 
a useful framework to conceptualise how unfair discrimination affects 
population health (Table 1). On this basis it appears that, despite their 
dominance in society, men may be subject to a wide range of unfair 
discriminatory practices over their entire lives, through multiple 
pathways, with generally harmful responses.
There are few studies exploring the issue of discrimination towards 
men in health services. In contrast, there is a large body of literature 
Table 1. Conceptualising discrimination as a determinant of population health
Aspects of discrimination
Type Defined in reference to constituent dominant and subordinate groups, and justifying ideology
Form Legal or illegal; institutional, structural, interpersonal; direct or indirect; overt or covert
Agency Perpetrated by state or by non-state actors (institutional or individuals)
Expression From verbal to violent; mental, physical, or sexual
Domain For example: at home; within family; at school; getting a job; at work; getting housing; getting credit or 
loans; getting medical care, purchasing other goods and services; by the media; from the police or in the 
courts; by other public agencies or social services; on the street or in a public setting
Level Individual, institutional, residential neighbourhood, political jurisdiction, regional economy
Cumulative exposure to discrimination
Timing Conception; infancy; childhood; adolescence; adulthood
Intensity
Frequency (acute, chronic)
Duration
Pathways of embodying discrimination (involving exposure, susceptibility and responses to)
#1 Economic and social deprivation: at home, in the neighbourhood and other socio-economic regions
#2 Toxic substances and hazardous conditions (pertaining to physical, chemical, and biological agents): at 
home, at work, and in the neighbourhood
#3 Socially inflicted trauma (mental, physical or sexual, ranging from verbal to violent): at home, at work, 
in the neighbourhood, in society at large
#4 Targeted marketing of legal and illegal psycho-active/other substances (alcohol, smoking, other drugs, 
junk food)
#5 Inadequate healthcare, by healthcare facilities and by specific providers (including access to care, 
diagnosis, treatment)
Responses to discrimination (protective and harmful)
Protective Active resistance by individuals and communities (involving organising, lawsuits, social networks, social 
support)
Creating safe spaces for self-affirmation (social, cultural, sexual)
Harmful Internalised oppression and denial
Use of psycho-active substances (legal and illegal)
Effects of discrimination on scientific knowledge
Theoretical frameworks
Specific hypotheses
Data collection
Data interpretation
*From: Berkman LF. Social Epidemiology. London, UK: Oxford University Press, 2000:42; reproduced with permission from Oxford University Press. 
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on discrimination and women’s health,[12-21] possibly in response to 
the historic under-representation of women in research informing 
medical practice. In 1993 the United States National Institutes of 
Health (NIH) was mandated by law to ensure that ‘women and 
minority groups’ were included in clinical research.[22] While this was 
a welcome response to an important omission from international 
research agendas, is it possible that the pendulum has swung too far? 
It seems probable that we are unable to recognise gender inequality 
when it affects men.
The priorities and programmes of large funders appear to confirm 
the focus on women in HIV/AIDS programmes. For example, the 
Global Fund for HIV/AIDS, Tuberculosis and Malaria – the largest 
multilateral HIV/AIDS funding agency – states that equitable access to 
services is fundamental to its mission but does not include men’s poorer 
access to ART as a key action area. The United States of America, 
the largest donor on HIV/AIDS, has provided funding for nearly 2.5 
million people living with HIV through its President’s Emergency Plan 
for AIDS Relief (PEPFAR) programme. Although disproportionately 
more women than men have accessed ART, PEPFAR does not prioritise 
increasing men’s access to treatment.
In turn, funders’ priorities may affect national ART programmes. In 
Zambia, 54% of those living with HIV, but 63% of adults starting ART, 
are women.[23] In South Africa, too, there is a gender gap: 55% of those 
living with HIV, but only an estimated 68% of those starting public 
sector ART, are women.[24] Yet, the national strategic plans for HIV/
AIDS in both countries do not identify male access to ART as a priority, 
nor do they include action plans to address this gap urgently. The same 
is true for many other African countries.
This apparent lack of concern for men’s needs extends beyond 
ART programmes to other arenas. Policy documents define gender 
as the ‘socially constructed roles, behaviours, activities and attributes’ 
considered appropriate for men and women in particular settings.
[10] In practice, however, it seems that gender and women’s issues 
are still regarded as interchangeable. For instance, South Africa has 
a ministry for women, children and people with disabilities, but 
nothing comparable for men. Similarly, the United Nations has an 
Inter-Agency Network on Women and Gender Equality and the 
third Millennium Development Goal for 2015 is to ‘promote gender 
equality and empower women’. The UNAIDS’s Operational Plan on 
gender addresses ‘women, girls, gender equality and HIV’, but none of 
the three action areas refers to the needs of men or boys. Clearly the 
initiatives listed above are vital, as are initiatives to address the health 
needs of men. In the words of WHO: ‘no one should be sick or die 
because of gender inequality’.
One last point for readers to consider: Many international and 
national conferences, including the recent conference of the Southern 
African HIV Clinicians Society, include tracks on women’s health, but 
not that of men. Is this because there are no HIV-related issues specific 
to men’s health – or is it because the question was not asked? 
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